Nanjing CR Medicon Technology Co., Ltd.
Nanjing CR Medicon Technology Co., Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GH2616 in Subjects With Advanced Solid Tumor. | Advanced Solid Tumor Cancer | Active, not recruiting | Phase 1 | 2025-12-03 | NCT07260513 |